Kenneth Gruber (IMAGE) University of Missouri-Columbia Caption Gruber is close to entering clinical trials for a drug that could delay a horrible side effect of cancer and give doctors additional time and treatment options for their patients. Credit Nathan Hurst/University of Missouri Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.